Charlie Gard To Die In Hospice

REUTERS/Peter Nicholls - RTX3CPL3

Daily Caller News Foundation logo
Joshua Gill Religion Reporter
Font Size:

A judge ruled Wednesday that Charlie Gard will die in hospice after the deadline passed for Gard’s parents to present alternative end of life options.

Justice Francis decided that Gard would die in hospice unless Chris Gard and Connie Yates, Gard’s parents, presented an alternative option by 12 p.m., to which the Great Ormond Street Hospital agreed. As his parents could not find viable alternative options, Gard is set to be taken into hospice care and taken off of life support “shortly after,” according to International Business Times.

Francis ruled that Gard’s time of death would be kept private. The decision to move Gard to hospice came after Gard’s parents decided Monday to end their appeal to have their son treated. Chris Gard said the decision to let their son die was now in his best interests, as it was too late to treat him with any hope of improvement, thanks to the prolonged intervention of the court.

“This is one of the hardest things we will have to say … this is about a sweet innocent boy born with a disease,” Chris Gard said. “We have decided it’s no longer in Charlie’s interest to have treatment. Our son is an absolute warrior and we will miss him. We are now going to spend our last precious moments with our son, we would ask our privacy is respected.”

Gard’s parents appealed Tuesday and Wednesday for their last wish to take their son home for a “few days of tranquility,” but representatives of the hospital argued that was impossible, and that even if Gard were to be taken into hospice, he would have to die the same day.

Follow Joshua on Twitter

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact